Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.09.17	Sphere ETFs Announces a Revision to September 2017 ex-Dividend Date (PR Newswire)
19.09.17	Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards (PR Newswire)
14.09.17	FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer (PR Newswire)
13.09.17	Aegon Announces Stock Fraction Interim Dividend 2017 (PR Newswire)
13.09.17	Aegon Announces Stock Fraction Interim Dividend 2017 (PR Newswire)
12.09.17	Allergan Launches New Brilliant Distinctions® Patient Loyalty Program (PR Newswire)
12.09.17	Unleashing the Power of the Latest Pharmaceutical Research for Simplified Global Healthcare Solutions through Conference Series Pharma meetings (PR Newswire)
11.09.17	The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts (PR Newswire)
09.09.17	Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress (PR Newswire)
08.09.17	Allergan Reveals Agreements Regarding RESTASIS Patents (RTTNews)
08.09.17	Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow's Feet With BOTOX® Cosmetic (onabotulinumtoxinA)1 (PR Newswire)
31.08.17	Apricus Biosciences Issues Update On Vitaros NDA Resubmission - Quick Facts (RTTNews)
30.08.17	Technical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSivida (PR Newswire)
28.08.17	Allergan Announces Settlement of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with Famy Care (PR Newswire)
28.08.17	The Allergan Foundation to Donate $100,000 to Support Hurricane Harvey Relief Efforts (PR Newswire)
25.08.17	Allergan to Present at the 2017 Morgan Stanley Global Healthcare Conference (PR Newswire)
24.08.17	Porter Novelli Strengthens North America Talent on Both Coasts (PR Newswire)
23.08.17	Allergan Teams Up With Comedian Vanessa Bayer and OB/GYN Jessica Shepherd, M.D., M.B.A, to Debut the Know Your Birth Control Campaign (PR Newswire)
22.08.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN (PR Newswire)
16.08.17	Allergan to Present at the 2017 Wells Fargo Healthcare Conference (PR Newswire)
16.08.17	ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) (PR Newswire)
10.08.17	Aegon Strengthens Dutch Capital Position and Reports Strong 2Q 2017 Results (PR Newswire)
10.08.17	Aegon Strengthens Dutch Capital Position and Reports Strong 2Q 2017 Results (PR Newswire)
10.08.17	Aegon to Divest Its Business in Ireland (PR Newswire)
10.08.17	Aegon to Divest Its Business in Ireland (PR Newswire)
09.08.17	ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit... (PR Newswire)
08.08.17	Aegon to Sell Unirobe Meeùs Groep (PR Newswire)
08.08.17	Aegon to Sell Unirobe Meeùs Groep (PR Newswire)
08.08.17	Aegon to Sell Unirobe Meeùs Groep (PR Newswire)
03.08.17	Options Trades for Allergan, 3D Systems, Regeneron Pharmaceuticals, Tesla Motors and Yelp include trade ideas that offer returns of 26% or more! (PR Newswire)
03.08.17	Allergan Q2 Attributable Net Loss Widens, Lifts Revenue Guidance For FY17 (RTTNews)
03.08.17	Allergan Inc. Reports 3% Rise In Q2 Profit (RTTNews)
03.08.17	Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion (PR Newswire)
02.08.17	Allergan Announces Third Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share (PR Newswire)
31.07.17	Amgen And Allergan Submit Biosimilar BLA For ABP 980 To FDA (RTTNews)
31.07.17	Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration (PR Newswire)
19.07.17	Joseph H. Boccuzi Appointed to Allergan plc Board of Directors (PR Newswire)
19.07.17	Technical Reports on Generic Drugs Equities -- Allergan, Ironwood Pharma, Medicines Co., and Catalent (PR Newswire)
14.07.17	FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% (RTTNews)
13.07.17	Allergan Lends Support to Broaden Uterine Fibroid Awareness Month (PR Newswire)
13.07.17	Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab) (PR Newswire)
13.07.17	NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track (RTTNews)
11.07.17	See America Furthers The Fight Against Preventable Blindness With #EyePic Campaign (PR Newswire)
05.07.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan, Inc. (AGN) & Lead Plaintiff Deadline: August 29, 2017 (PR Newswire)
03.07.17	Allergan to Report Second Quarter 2017 Earnings and Host Conference Call and Webcast (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	500.80	1.23 %	K V
Zurich Insur Gr	534.60	0.98 %	K V
Swisscom	511.00	0.69 %	K V
Swiss Re	133.20	0.68 %	K V
Givaudan	3’870.00	0.57 %	K V
Novartis	90.03	-0.09 %	K V
Nestle	73.58	-0.78 %	K V
Part Grp Hldg	1’278.50	-0.97 %	K V
Alcon	74.90	-1.06 %	K V
CieFinRichemont	138.70	-1.07 %	K V

mehr

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan